EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns—A Narrative Review

Marcin Rzeszutek iD, Tomasz Wolańczyk

Journal of Clinical Medicine · 17.10.2025 · 14 (20) · 7338

DOI: 10.3390/jcm14207338 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.10.2025. Verfasst von Marcin Rzeszutek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child Psychiatry, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition frequently treated with pharmacological interventions, most commonly stimulants such as methylphenidate and amphetamines, alongside non-stimulant options. This narrative review, based on 31 publications and five national drug utilization registers, summarizes global trends in ADHD medication use since 2000. Across most countries, prevalence of ADHD medication use increased steadily, with the sole exception of the Netherlands, where recent declines were observed. The highest prevalence of ADHD medication use was consistently found among older children and adolescents. While boys showed higher values of prevalence of ADHD medication use than girls in childhood, faster increases among females resulted in reversed gender ratios in several adult populations. Methylphenidate remained the most widely prescribed drug, although the use of lisdexamfetamine and guanfacine has expanded in recent years. Variations in national guidelines, diagnostic frameworks, healthcare access, and sociocultural acceptance of pharmacotherapy contributed to observed differences across regions. Increasing use of ADHD medications raises important questions about equitable access to treatment, potential overdiagnosis, and the risk of stimulant misuse. These findings highlight the need for continued monitoring of utilization patterns to ensure safe, rational, and equitable ADHD care worldwide.

Schlagwörter

Stichwörter der Autor:innen

amphetamineatomoxetineconsumptiondexamfetamineguanfacinelisdexamfetaminemethylphenidateprevalencestimulantsutilization

Autor:innen und Institutionen

  • Department of Child Psychiatry, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland.

ORCID-Profile: Marcin Rzeszutek

Zitieren

APA

Rzeszutek, M., & Wolańczyk, T. (2025). Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns—A Narrative Review. Journal of Clinical Medicine, 14(20), 7338. https://doi.org/10.3390/jcm14207338

Vancouver

Rzeszutek M, Wolańczyk T. Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns—A Narrative Review. Journal of Clinical Medicine. 2025;14(20):7338. doi:10.3390/jcm14207338

BibTeX
@article{Rzeszutek2025,
  author = {Rzeszutek, Marcin and Wolańczyk, Tomasz},
  title = {Global Trends in ADHD Medication Use: Multiple Contexts and Rising Concerns—A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {20},
  pages = {7338},
  doi = {10.3390/jcm14207338}
}
Kostenlos starten →